SLC2A5 and neoplasm: Cairns et al. found that AML cells under low glucose conditions markedly upregulate GLUT5 expression, enabling fructose uptake and its subsequent conversion into glycolytic intermediates, thereby sustaining tumor cell survival and proliferation 105.